Chiara Falciani

2.5k total citations
83 papers, 2.1k citations indexed

About

Chiara Falciani is a scholar working on Molecular Biology, Microbiology and Organic Chemistry. According to data from OpenAlex, Chiara Falciani has authored 83 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 34 papers in Microbiology and 15 papers in Organic Chemistry. Recurrent topics in Chiara Falciani's work include Antimicrobial Peptides and Activities (32 papers), Glycosylation and Glycoproteins Research (13 papers) and Chemical Synthesis and Analysis (12 papers). Chiara Falciani is often cited by papers focused on Antimicrobial Peptides and Activities (32 papers), Glycosylation and Glycoproteins Research (13 papers) and Chemical Synthesis and Analysis (12 papers). Chiara Falciani collaborates with scholars based in Italy, Spain and Netherlands. Chiara Falciani's co-authors include Luisa Bracci, Alessandro Pini, Jlenia Brunetti, Barbara Lelli, Luisa Lozzi, Silvia Scali, Gian María Rossolini, Stefano Menichetti, Paolo Neri and Ylenia Runci and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Chiara Falciani

79 papers receiving 2.1k citations

Peers

Countries citing papers authored by Chiara Falciani

Since Specialization

Citations

This map shows the geographic impact of Chiara Falciani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Falciani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Falciani more than expected).

Fields of papers citing papers by Chiara Falciani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Falciani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Falciani. The network helps show where Chiara Falciani may publish in the future.

Co-authorship network of co-authors of Chiara Falciani

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Falciani. A scholar is included among the top collaborators of Chiara Falciani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Falciani. Chiara Falciani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A peptide-based medical device for the selective removal of inflammatory factors from the blood of people with sepsis 2025 ·Communications Medicine ·Giovanni Cappello, Laura Cresti, (unknown), Letizia Bocchi, Elena Bianchini, Filippo Carlucci, (unknown), Jlenia Brunetti, Chiara Falciani, Luisa Bracci, Alessandro Pini	0
2	The Synergetic Effect of Periodontal Therapy and TNF‐α Inhibitor for the Treatment of Comorbid Periodontitis and Psoriasis 2025 ·Journal Of Clinical Periodontology ·Crystal Marruganti, Carlo Gaeta, Chiara Falciani, Élisa Cinotti, Pietro Rubegni, Mario Alovisi, Nicola Scotti, Andrea Baldi, Cristiana Bellan, (unknown), (unknown), Fabio Fiorino, Silvia Valensin, E. Bellini, Antonella Rosa, Filippo Graziani, Francesco D’Aiuto, Simone Grandini	1
3	Antimicrobial Peptides SET-M33L and SET-M33L-PEG Are Promising Agents Against Strong Biofilm-Forming P. aeruginosa, Including Multidrug-Resistant Isolates 2025 ·Antibiotics ·(unknown), P Croughs, (unknown), Adrianus C. J. M. de Bruijn, Chiara Falciani, Alessandro Pini, Isabella Ellinger, Wendy W. J. Unger, John P. Hays	0
4	A Compact Prism‐Based Microscope for Highly Sensitive Measurements in Fluid Biopsy 2025 ·Journal of Biophotonics ·(unknown), (unknown), Chiara Falciani, Alessandro Pini, Lucia Gardini, Caterina Credi, Francesco S. Pavone	1
5	Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 2025 ·Frontiers in Cell and Developmental Biology ·Lorenzo Depau, Jlenia Brunetti, Chiara Falciani, (unknown), (unknown), (unknown), (unknown), Alessandro Pini, Luisa Bracci	0
6	Are periodontitis and psoriasis associated? A pre‐clinical murine model 2024 ·Journal Of Clinical Periodontology ·Crystal Marruganti, Carlo Gaeta, Chiara Falciani, Élisa Cinotti, Pietro Rubegni, Mario Alovisi, Nicola Scotti, Andrea Baldi, Cristiana Bellan, (unknown), Fabio Fiorino, Silvia Valensin, E. Bellini, Antonella Rosa, Francesco D’Aiuto, Simone Grandini	2
7	The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide 2022 ·Pharmaceutics ·(unknown), (unknown), Hassan El Btaouri, (unknown), Pascal Sonnet, Laurent Martiny, (unknown), Chiara Falciani, Catherine Sarazin, Nicola D’Amelio	6
8	Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer 2021 ·Frontiers in Oncology ·Simone Furini, Chiara Falciani	16
9	Antimicrobial Peptide-Loaded Nanoparticles as Inhalation Therapy for Pseudomonas aeruginosa Infections 2020 ·SHILAP Revista de lepidopterología ·Chiara Falciani, (unknown), Jlenia Brunetti, Giulia Riolo, Raquel Gracia, Marco Marradi, (unknown), Christina Ziemann, Unai Cossío, J. M. Llop Talaverón, Luisa Bracci, Alessandro Pini	1
10	<p>Antimicrobial Peptide-Loaded Nanoparticles as Inhalation Therapy for <em>Pseudomonas aeruginosa</em> Infections</p> 2020 ·International Journal of Nanomedicine ·Chiara Falciani, (unknown), Jlenia Brunetti, Giulia Riolo, Raquel Gracia, Marco Marradi, Iraida Loinaz, Christina Ziemann, Unai Cossío, Jordi Llop, Luisa Bracci, Alessandro Pini	83
11	Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumon iae and P. aeruginosa 2017 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), Jlenia Brunetti, Alessandro Pini, Luisa Bracci, (unknown), Pietro Lupetti, Eugenio Paccagnini, Mariangela Gentile, Andrea Bernini, Neri Niccolai, (unknown), Irma A. J. M. Bakker‐Woudenberg, Wil H. F. Goessens, John P. Hays, Chiara Falciani	27
12	In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 2016 ·Scientific Reports ·Jlenia Brunetti, Chiara Falciani, (unknown), Simona Pollini, Stefano Bindi, Silvia Scali, Unai Cossío, Vanessa Gómez‐Vallejo, (unknown), (unknown), Marco Prato, Gian María Rossolini, Jordi Llop, Luisa Bracci, Alessandro Pini	73
13	Neurotensin Branched Peptide as a Tumor-Targeting Agent for Human Bladder Cancer 2015 ·BioMed Research International ·Jlenia Brunetti, Chiara Falciani, Barbara Lelli, Andrea Minervini, (unknown), Lorenzo Depau, Giampaolo Siena, (unknown), Stefano Menichetti, Alessandro Pini, Marco Carini, Luisa Bracci	26
14	Target‐Selective Drug Delivery through Liposomes Labeled with Oligobranched Neurotensin Peptides 2011 ·ChemMedChem ·Chiara Falciani, Antonella Accardo, Jlenia Brunetti, Diego Tesauro, Barbara Lelli, Alessandro Pini, Luisa Bracci, Giancarlo Morelli	42
15	Design and In vitro Evaluation of Branched Peptide Conjugates: Turning Nonspecific Cytotoxic Drugs into Tumor‐Selective Agents 2010 ·ChemMedChem ·Chiara Falciani, Jlenia Brunetti, Chiara Pagliuca, Stefano Menichetti, (unknown), Barbara Lelli, Alessandro Pini, Luisa Bracci	44
16	Oligo-branched peptides for tumor targeting: from magic bullets to magic forks 2009 ·Expert Opinion on Biological Therapy ·Chiara Falciani, Alessandro Pini, Luisa Bracci	19
17	Branched Peptides as Therapeutics 2008 ·Current Protein and Peptide Science ·Alessandro Pini, Chiara Falciani, Luisa Bracci	68
18	A Multidisciplinary Approach for the Identification of Novel HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors: S‐DABOCs and DAVPs 2007 ·ChemMedChem ·Marco Radi, Chiara Falciani, (unknown), Elena Petricci, Giovanni Maga, Alberta Samuele, Samantha Zanoli, Montserrat Terrazas, (unknown), (unknown), José A. Esté, Imma Clotet‐Codina, Mercedes Armand‐Ugón, Maurizio Botta	32
19	Rational Design and Molecular Diversity for the Construction of Anti-α-Bungarotoxin Antidotes with High Affinity and In Vivo Efficiency 2003 ·Chemistry & Biology ·Luisa Lozzi, Barbara Lelli, Ylenia Runci, Silvia Scali, Andrea Bernini, Chiara Falciani, Alessandro Pini, Neri Niccolai, Paolo Neri, Luisa Bracci	20
20	ortho-Thioquinones, New Acceptors for the Stereoselective Synthesis of Aryl 2-Deoxy-O-Glycosides 1999 ·Chemistry - A European Journal ·Giuseppe Capozzi, Chiara Falciani, Stefano Menichetti, Cristina Nativi, (unknown)	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact